Arch Biopartners Receives Permission From U.S. FDA to Proceed With Phase II Acute Kidney Injury Trial Approval from FDA to initiate Phase II trial with LSALT peptide to target cardiac surgery-associated acute kidney injury (CS-AKI)LSALT peptide targets dipeptidase-1 (DPEP-1), an enzyme known to...

Circana Launches Audiences for Toys and Prestige Beauty CHICAGO, March 20, 2023 (GLOBE NEWSWIRE) -- Circana, formerly IRI and The NPD Group, today announced the availability of Circana Audiences for two general merchandise industries: toys and prestige...

Meeting US Consumers’ Desire for Both Nutrition and Indulgence Helped CPG Leaders Grow in a Sluggish 2016 CHICAGO, March 06, 2017 (GLOBE NEWSWIRE) -- In an otherwise lackluster year for US sales of consumer packaged goods (CPG), many of the industry’s top performers in 2016 generated growth by...